CMMB

Chemomab Therapeutics Ltd.

0.66 USD
+0.00 (+0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Chemomab Therapeutics Ltd. stock is up 8.21% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 March’s closed higher than February.

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24.